Complement Inactivating Agents
"Complement Inactivating Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host.
| Descriptor ID |
D051056
|
| MeSH Number(s) |
D27.505.696.477.656.500
|
| Concept/Terms |
Complement Inactivating Agents- Complement Inactivating Agents
- Agents, Complement Inactivating
- Inactivating Agents, Complement
- Complement Inhibitors
- Inhibitors, Complement
- Complement Inhibiting Agents
- Agents, Complement Inhibiting
- Inhibiting Agents, Complement
|
Below are MeSH descriptors whose meaning is more general than "Complement Inactivating Agents".
Below are MeSH descriptors whose meaning is more specific than "Complement Inactivating Agents".
This graph shows the total number of publications written about "Complement Inactivating Agents" by people in this website by year, and whether "Complement Inactivating Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 1 | 3 |
| 2018 | 2 | 2 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 5 | 1 | 6 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Complement Inactivating Agents" by people in Profiles.
-
Diagnostic Considerations in H1N1 Influenza-induced Thrombotic Microangiopathy. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e237-e240.
-
The case of complement inhibitors. Adv Biol Regul. 2021 08; 81:100822.
-
COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood. 2021 07 01; 137(26):3670-3673.
-
Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy. Front Immunol. 2021; 12:680567.
-
Course of COVID-19 Pneumonia in a Kidney Transplant Patient Receiving Eculizumab. Prog Transplant. 2021 09; 31(3):279-280.
-
COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria: A case report. Medicine (Baltimore). 2021 May 21; 100(20):e25456.
-
Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic. Int Urol Nephrol. 2022 Feb; 54(2):459-460.
-
An update: the emerging evidence of complement involvement in COVID-19. Med Microbiol Immunol. 2021 Jun; 210(2-3):101-109.
-
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. Pharmacol Rev. 2021 04; 73(2):792-827.
-
Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol. 2021 05; 226:108716.